Marktanalyse - Colorectal Cancer - Pipeline Review, H2 2016

Global Markets Direct
12.2016
1645 Seiten

 
Typ:
Marktanalyse
Verfüg­barkeit:
verfügbar
Regionen/­Länder:
  • Europa
  • Asien / Pazifik
  • Mittlerer Osten / Afrika
  • Nordamerika / USA
  • Australien
  • Mittel- / Südamerika
Sprache:
Englisch

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

PDF-Datei per E-Mail, Single User Price, versandkostenfrei
PDF-Datei per E-Mail, Site License Price**, versandkostenfrei
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)***, versandkostenfrei


Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Colorectal Cancer - Pipeline Review, H2 2016


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer — Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer — Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 26, 106, 110, 9, 145, 36 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 15, 8, 22 and 3 molecules, respectively.

Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)


Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents

Table of Contents 2

Introduction 12

Colorectal Cancer Overview 13

Therapeutics Development 14

Colorectal Cancer - Therapeutics under Development by Companies 16

Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes 36

Colorectal Cancer - Pipeline Products Glance 38

Colorectal Cancer - Products under Development by Companies 42

Colorectal Cancer - Products under Investigation by Universities/Institutes 71

Colorectal Cancer - Companies Involved in Therapeutics Development 74

Colorectal Cancer - Therapeutics Assessment 312

Drug Profiles 359

Colorectal Cancer - Dormant Projects 1545

Colorectal Cancer - Discontinued Products 1576

Colorectal Cancer - Product Development Milestones 1584

Appendix 1593





List of Tables

Number of Products under Development for Colorectal Cancer, H2 2016 65

Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2016 66

Number of Products under Development by Companies, H2 2016 68

Number of Products under Development by Companies, H2 2016 (Contd..1) 69

Number of Products under Development by Companies, H2 2016 (Contd..2) 70

Number of Products under Development by Companies, H2 2016 (Contd..3) 71

Number of Products under Development by Companies, H2 2016 (Contd..4) 72

Number of Products under Development by Companies, H2 2016 (Contd..5) 73

Number of Products under Development by Companies, H2 2016 (Contd..6) 74

Number of Products under Development by Companies, H2 2016 (Contd..7) 75

Number of Products under Development by Companies, H2 2016 (Contd..8) 76

Number of Products under Development by Companies, H2 2016 (Contd..9) 77

Number of Products under Development by Companies, H2 2016 (Contd..10) 78

Number of Products under Development by Companies, H2 2016 (Contd..11) 79

Number of Products under Development by Companies, H2 2016 (Contd..12) 80

Number of Products under Development by Companies, H2 2016 (Contd..13) 81

Number of Products under Development by Companies, H2 2016 (Contd..14) 82

Number of Products under Development by Companies, H2 2016 (Contd..15) 83

Number of Products under Development by Companies, H2 2016 (Contd..16) 84

Number of Products under Development by Companies, H2 2016 (Contd..17) 85

Number of Products under Development by Companies, H2 2016 (Contd..18) 86

Number of Products under Investigation by Universities/Institutes, H2 2016 87

Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88

Comparative Analysis by Late Stage Development, H2 2016 89

Comparative Analysis by Clinical Stage Development, H2 2016 90

Comparative Analysis by Early Stage Development, H2 2016 91

Comparative Analysis by Unknown Stage Development, H2 2016 92

Products under Development by Companies, H2 2016 93

Products under Development by Companies, H2 2016 (Contd..1) 94

Products under Development by Companies, H2 2016 (Contd..2) 95

Products under Development by Companies, H2 2016 (Contd..3) 96

Products under Development by Companies, H2 2016 (Contd..4) 97

Products under Development by Companies, H2 2016 (Contd..5) 98

Products under Development by Companies, H2 2016 (Contd..6) 99

Products under Development by Companies, H2 2016 (Contd..7) 100

Products under Development by Companies, H2 2016 (Contd..8) 101

Products under Development by Companies, H2 2016 (Contd..9) 102

Products under Development by Companies, H2 2016 (Contd..10) 103

Products under Development by Companies, H2 2016 (Contd..11) 104

Products under Development by Companies, H2 2016 (Contd..12) 105

Products under Development by Companies, H2 2016 (Contd..13) 106

Products under Development by Companies, H2 2016 (Contd..14) 107

Products under Development by Companies, H2 2016 (Contd..15) 108

Products under Development by Companies, H2 2016 (Contd..16) 109

Products under Development by Companies, H2 2016 (Contd..17) 110

Products under Development by Companies, H2 2016 (Contd..18) 111

Products under Development by Companies, H2 2016 (Contd..19) 112

Products under Development by Companies, H2 2016 (Contd..20) 113

Products under Development by Companies, H2 2016 (Contd..21) 114

Products under Development by Companies, H2 2016 (Contd..22) 115

Products under Development by Companies, H2 2016 (Contd..23) 116

Products under Development by Companies, H2 2016 (Contd..24) 117

Products under Development by Companies, H2 2016 (Contd..25) 118

Products under Development by Companies, H2 2016 (Contd..26) 119

Products under Development by Companies, H2 2016 (Contd..27) 120

Products under Development by Companies, H2 2016 (Contd..28) 121

Products under Investigation by Universities/Institutes, H2 2016 122

Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 123

Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 124

Colorectal Cancer - Pipeline by 2cureX ApS, H2 2016 125

Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H2 2016 126

Colorectal Cancer - Pipeline by 3M Drug Delivery Systems, H2 2016 127

Colorectal Cancer - Pipeline by 3SBio Inc, H2 2016 128

Colorectal Cancer - Pipeline by 4SC AG, H2 2016 129

Colorectal Cancer - Pipeline by AB Science SA, H2 2016 130

Colorectal Cancer - Pipeline by AbbVie Inc, H2 2016 131

Colorectal Cancer - Pipeline by AbGenomics International Inc, H2 2016 132

Colorectal Cancer - Pipeline by Accelerated Pharma Inc, H2 2016 133

Colorectal Cancer - Pipeline by Adamed Sp z oo, H2 2016 134

Colorectal Cancer - Pipeline by Aduro BioTech Inc, H2 2016 135

Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H2 2016 136

Colorectal Cancer - Pipeline by Alchemia Ltd, H2 2016 137

Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2016 138

Colorectal Cancer - Pipeline by Amal Therapeutics SA, H2 2016 139

Colorectal Cancer - Pipeline by amcure GmbH, H2 2016 140

Colorectal Cancer - Pipeline by Amgen Inc, H2 2016 141

Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H2 2016 142

Colorectal Cancer - Pipeline by Apac Biotech Pvt Ltd, H2 2016 143

Colorectal Cancer - Pipeline by Apexigen Inc, H2 2016 144

Colorectal Cancer - Pipeline by Aphios Corp, H2 2016 145

Colorectal Cancer - Pipeline by Aposense Ltd, H2 2016 146

Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals Inc, H2 2016 147

Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H2 2016 148

Colorectal Cancer - Pipeline by ArQule Inc, H2 2016 149

Colorectal Cancer - Pipeline by Array BioPharma Inc, H2 2016 150

Colorectal Cancer - Pipeline by Asana BioSciences LLC, H2 2016 151

Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2016 152

Colorectal Cancer - Pipeline by Astellas Pharma Inc, H2 2016 153

Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2016 154

Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2016 155

Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2016 156

Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2016 157

Colorectal Cancer - Pipeline by B Cell Design SAS, H2 2016 158

Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H2 2016 159

Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2016 160

Colorectal Cancer - Pipeline by Bayer AG, H2 2016 161

Colorectal Cancer - Pipeline by BeiGene Ltd, H2 2016 162

Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H2 2016 163

Colorectal Cancer - Pipeline by Biocon Ltd, H2 2016 164

Colorectal Cancer - Pipeline by Bionomics Ltd, H2 2016 165

Colorectal Cancer - Pipeline by Bionovis SA, H2 2016 166

Colorectal Cancer - Pipeline by Biotecnol Ltd, H2 2016 167

Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H2 2016 168

Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016 169

Colorectal Cancer - Pipeline by Boston Biomedical Inc, H2 2016 170

Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016 171

Colorectal Cancer - Pipeline by Burzynski Research Institute Inc, H2 2016 172

Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H2 2016 173

Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2016 174

Colorectal Cancer - Pipeline by Carna Biosciences Inc, H2 2016 175

Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc, H2 2016 176

Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc, H2 2016 177

Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2016 178

Colorectal Cancer - Pipeline by Celgene Corp, H2 2016 179

Colorectal Cancer - Pipeline by Cellceutix Corp, H2 2016 180

Colorectal Cancer - Pipeline by Celldex Therapeutics Inc, H2 2016 181

Colorectal Cancer - Pipeline by Cellectar Biosciences Inc, H2 2016 182

Colorectal Cancer - Pipeline by Celltrion Inc, H2 2016 183

Colorectal Cancer - Pipeline by Celyad SA, H2 2016 184

Colorectal Cancer - Pipeline by Chiome Bioscience Inc, H2 2016 185

Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2016 186

Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd, H2 2016 187

Colorectal Cancer - Pipeline by Cipla Ltd, H2 2016 188

Colorectal Cancer - Pipeline by Cleave Biosciences Inc, H2 2016 189

Colorectal Cancer - Pipeline by Cleveland BioLabs Inc, H2 2016 190

Colorectal Cancer - Pipeline by COARE Biotechnology Inc, H2 2016 191

Colorectal Cancer - Pipeline by Coherus BioSciences Inc, H2 2016 192

Colorectal Cancer - Pipeline by Compugen Ltd, H2 2016 193

Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals Inc, H2 2016 194

Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc, H2 2016 195

Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc, H2 2016 196

Colorectal Cancer - Pipeline by CrystalGenomics Inc, H2 2016 197

Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2016 198

Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd, H2 2016 199

Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2016 200

Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC, H2 2016 201

Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals Inc, H2 2016 202

Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2016 203

Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2016 204

Colorectal Cancer - Pipeline by EirGenix Inc, H2 2016 205

Colorectal Cancer - Pipeline by Eisai Co Ltd, H2 2016 206

Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2016 207

Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2016 208

Colorectal Cancer - Pipeline by enGene Inc, H2 2016 209

Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2016 210

Colorectal Cancer - Pipeline by Ensol Biosciences Inc, H2 2016 211

Colorectal Cancer - Pipeline by EntreChem SL, H2 2016 212

Colorectal Cancer - Pipeline by Enzo Biochem Inc, H2 2016 213

Colorectal Cancer - Pipeline by Etubics Corp, H2 2016 214

Colorectal Cancer - Pipeline by Exelixis Inc, H2 2016 215

Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2016 216

Colorectal Cancer - Pipeline by Five Prime Therapeutics Inc, H2 2016 217

Colorectal Cancer - Pipeline by Formosa Laboratories Inc, H2 2016 218

Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd, H2 2016 220

Colorectal Cancer - Pipeline by Genentech Inc, H2 2016 221

Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd, H2 2016 222

Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2016 223

Colorectal Cancer - Pipeline by Genzyme Corp, H2 2016 224

Colorectal Cancer - Pipeline by Gilead Sciences Inc, H2 2016 225

Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016 226

Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2016 227

Colorectal Cancer - Pipeline by Golden Biotechnology Corp, H2 2016 228

Colorectal Cancer - Pipeline by Green Cross Corp, H2 2016 229

Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016 230

Colorectal Cancer - Pipeline by Handok Inc, H2 2016 231

Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2016 232

Colorectal Cancer - Pipeline by Heat Biologics Inc, H2 2016 233

Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc, H2 2016 234

Colorectal Cancer - Pipeline by Hutchison MediPharma Ltd, H2 2016 235

Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2016 236

Colorectal Cancer - Pipeline by Ideaya Biosciences Inc, H2 2016 237

Colorectal Cancer - Pipeline by Ignyta Inc, H2 2016 238

Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd, H2 2016 239

Colorectal Cancer - Pipeline by ImmuneXcite Inc, H2 2016 240

Colorectal Cancer - Pipeline by Immunomedics Inc, H2 2016 241

Colorectal Cancer - Pipeline by Immunovative Therapies Ltd, H2 2016 242

Colorectal Cancer - Pipeline by Incanthera Ltd, H2 2016 243

Colorectal Cancer - Pipeline by Incyte Corp, H2 2016 244

Colorectal Cancer - Pipeline by Innovent Biologics Inc, H2 2016 245

Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2016 246

Colorectal Cancer - Pipeline by Interprotein Corp, H2 2016 247

Colorectal Cancer - Pipeline by Intezyne Technologies Inc, H2 2016 248

Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc, H2 2016 249

Colorectal Cancer - Pipeline by IPD Therapeutics BV, H2 2016 250

Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2016 251

Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2016 252

Colorectal Cancer - Pipeline by JHL Biotech Inc, H2 2016 253

Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2016 254

Colorectal Cancer - Pipeline by Johnson & Johnson, H2 2016 255

Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals Inc, H2 2016 256

Colorectal Cancer - Pipeline by Kancera AB, H2 2016 257

Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc, H2 2016 258

Colorectal Cancer - Pipeline by Kura Oncology Inc, H2 2016 259

Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A, H2 2016 260

Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2016 261

Colorectal Cancer - Pipeline by Lion Biotechnologies Inc, H2 2016 262

Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc, H2 2016 263

Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2016 264

Colorectal Cancer - Pipeline by Mabion SA, H2 2016 265

Colorectal Cancer - Pipeline by Mabtech Ltd, H2 2016 266

Colorectal Cancer - Pipeline by mAbxience SA, H2 2016 267

Colorectal Cancer - Pipeline by MacroGenics Inc, H2 2016 268

Colorectal Cancer - Pipeline by Marina Biotech Inc, H2 2016 269

Colorectal Cancer - Pipeline by MediaPharma srl, H2 2016 270

Colorectal Cancer - Pipeline by MedImmune LLC, H2 2016 271

Colorectal Cancer - Pipeline by Medinet Co Ltd, H2 2016 272

Colorectal Cancer - Pipeline by Merck & Co Inc, H2 2016 273

Colorectal Cancer - Pipeline by Merck KGaA, H2 2016 274

Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H2 2016 275

Colorectal Cancer - Pipeline by Merus NV, H2 2016 276

Colorectal Cancer - Pipeline by Microlin Bio, Inc., H2 2016 277

Colorectal Cancer - Pipeline by MolMed SpA, H2 2016 278

Colorectal Cancer - Pipeline by Mologen AG, H2 2016 279

Colorectal Cancer - Pipeline by Morphotek Inc, H2 2016 280

Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2016 281

Colorectal Cancer - Pipeline by Mycenax Biotech Inc, H2 2016 282

Colorectal Cancer - Pipeline by Natco Pharma Ltd, H2 2016 283

Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp, H2 2016 284

Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2016 285

Colorectal Cancer - Pipeline by Neovacs SA, H2 2016 286

Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl, H2 2016 287

Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd, H2 2016 288

Colorectal Cancer - Pipeline by NormOxys Inc, H2 2016 289

Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc, H2 2016 290

Colorectal Cancer - Pipeline by Novartis AG, H2 2016 291

Colorectal Cancer - Pipeline by Novogen Ltd, H2 2016 292

Colorectal Cancer - Pipeline by Noxxon Pharma AG, H2 2016 293

Colorectal Cancer - Pipeline by NuCana BioMed Ltd, H2 2016 294

Colorectal Cancer - Pipeline by OBI Pharma Inc, H2 2016 295

Colorectal Cancer - Pipeline by Oncobiologics Inc, H2 2016 296

Colorectal Cancer - Pipeline by Oncolytics Biotech Inc, H2 2016 297

Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H2 2016 298

Colorectal Cancer - Pipeline by Onconova Therapeutics Inc, H2 2016 299

Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2016 300





List of Figures

Number of Products under Development for Colorectal Cancer, H2 2016 65

Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2016 66

Number of Products under Development by Companies, H2 2016 67

Number of Products under Investigation by Universities/Institutes, H2 2016 87

Comparative Analysis by Late Stage Development, H2 2016 89

Comparative Analysis by Clinical Stage Development, H2 2016 90

Comparative Analysis by Early Stage Products, H2 2016 91

Assessment by Monotherapy Products, H2 2016 363

Assessment by Combination Products, H2 2016 364

Number of Products by Top 10 Targets, H2 2016 365

Number of Products by Stage and Top 10 Targets, H2 2016 365

Number of Products by Top 10 Mechanism of Actions, H2 2016 385

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 385

Number of Products by Top 10 Routes of Administration, H2 2016 406

Number of Products by Stage and Top 10 Routes of Administration, H2 2016 406

Number of Products by Top 10 Molecule Types, H2 2016 408

Number of Products by Stage and Top 10 Molecule Types, H2 2016 408

* Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

 

Über marktforschung.de

Branchenwissen an zentraler Stelle bündeln und abrufbar machen – das ist das Hauptanliegen von marktforschung.de. Unser breites Informationsangebot rund um die Marktforschung richtet sich sowohl an Marktforschungsinstitute, Felddienstleister, Panelbetreiber und Herausgeber von Studien, Marktdaten sowie Marktanalysen als auch an deren Kunden aus Industrie, Handel und Dienstleistungsgewerbe.

facebook twitter google plus